Cabot Corp.'s stock falls 10% after chemicals maker sees 'soft' global demand
Shares of Cabot Corp. (CBT) dropped by as much as 10% in the extended session Thursday after the specialty chemicals maker said its sales have slowed, as China's recovery hasn't materialized in the way that the company expected and global demand remains "soft," and dialed back on its outlook for the year. Sales in Cabot's performance chemicals business for April and May were 13% lower than the same months of 2022, with declines across all product lines except battery materials, the company said. "We are not seeing the anticipated pace of recovery in China after a challenging March quarter in the performance chemicals segment," Chief Executive Sean Keohane said in a statement. "In addition to the weakness in China, we continue to see soft demand on a global basis across many of our key end markets, including construction and consumer applications." Cabot said it expects EBIT for the segment to be "only modestly higher" quarter-on-quarter. In Cabot's reinforcement materials segment, volumes were down 8% for April and May as compared to last year's April and May with declines across all regions and mostly in the replacement tire market, the company said. Cabot kept its expectations of "stronger" adjusted EPS in the second half of its fiscal year, but not by as much as it had guided. Cabot is "no longer expecting adjusted earnings per share for fiscal 2023 to be in the range of $6.10 to $6.50," Keohane said. "We are focused on reducing costs in the near-term and we believe our investments have us well positioned for long-term growth." Keohane said that the company will provide a more complete outlook update by early August, when it reports fiscal third-quarter earnings.
-Claudia Assis
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-15-23 1724ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
How to Invest Like Warren Buffett
-
Cognizant Earnings: Improved Profitability Buttresses Results as Customer Spending Remains Muted
-
10 Top-Performing Dividend Stocks of the Month